• 78 Citations
  • 2 Scopus h-Index
20152019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Brenda Ernst is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Janus Kinase 1 Medicine & Life Sciences
Janus Kinase 2 Medicine & Life Sciences
Hot Flashes Medicine & Life Sciences
Primary Myelofibrosis Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2015 2019

  • 78 Citations
  • 2 Scopus h-Index
  • 4 Article
  • 1 Review article

Depomedroxyprogesterone acetate therapy for hot flashes in survivors of breast cancer: no unfavorable impact on recurrence and survival

Ertz-Archambault, N. M., Rogoff, L. B., Kosiorek, H. E., Ernst, B., Anderson, K. S., Pockaj, B. A., Gray, R. J. & Northfelt, D. W., Jan 1 2019, (Accepted/In press) In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Hot Flashes
Survivors
Acetates
Breast Neoplasms
Recurrence
1 Citation (Scopus)

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

McDonald, B. R., Contente-Cuomo, T., Sammut, S. J., Odenheimer-Bergman, A., Ernst, B., Perdigones, N., Chin, S. F., Farooq, M., Mejia, R., Cronin, P. A., Anderson, K. S., Kosiorek, H. E., Northfelt, D. W., McCullough, A. E., Patel, B., Weitzel, J. N., Slavin, T. P., Caldas, C., Pockaj, B. A. & Murtaza, M., Aug 7 2019, In : Science translational medicine. 11, 504, eaax7392.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Breast Neoplasms
DNA
Neoplasms
Alleles

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Lymphoma
Pharmaceutical Preparations
Maximum Tolerated Dose
Neutropenia
Hodgkin Disease
33 Citations (Scopus)

Immunotherapy for the Treatment of Breast Cancer

Ernst, B. & Anderson, K. S., Jan 1 2015, In : Current oncology reports. 17, 2

Research output: Contribution to journalReview article

Immunotherapy
Breast Neoplasms
Cancer Vaccines
Neoplasm Antigens
Lung Neoplasms
44 Citations (Scopus)

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

Shanavas, M., Popat, U., Michaelis, L. C., Fauble, V., McLornan, D., Klisovic, R., Mascarenhas, J., Tamari, R., Arcasoy, M. O., Davies, J., Gergis, U., Ukaegbu, O. C., Kamble, R. T., Storring, J. M., Majhail, N. S., Romee, R., Verstovsek, S., Pagliuca, A., Vasu, S., Ernst, B. & 5 others, Atenafu, E. G., Hanif, A., Champlin, R., Hari, P. & Gupta, V., Sep 10 2015, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Janus Kinase 1
Janus Kinase 2
Primary Myelofibrosis
Cell Transplantation
Behavior Therapy